4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-005053
Chief Executive Officer sold 11,096 shares at $3.19 ($35,416)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2022-01-18 | Sale | −11,096 | $3.19 | $35,416 | 12,312 | D |
| Open-market sales · 11,096 sh · avg $3.19 · $35,416 | |||||||
Loading xslF345X03/tm221700-15_4seq.xml…